The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization, is proud to announce the launch of the first eight Early Adopter Health Network (EAHN™) innovation projects.

OBIO’s Health to Business Bridge™ Program (H2BB) prepares new hires for careers in Ontario’s health science industry, helping companies build for the future in an innovative sector poised for growth.

This is a call to action for companies developing health technologies including COVID-19 management and treatment technologies to be evaluated for commercial readiness within its Early Adopter Health Network

The Ontario Bioscience Innovation Organization (OBIO®), a not-for-profit organization dedicated to advancing health technology innovation and commercialization in Ontario, announce today’s launch of the province’s first-of-its-kind Early Adopter Health Network (EAHN). The EAHN is a network of health organizations that get leading-edge technologies into the health system.

Last week, 43 of the most promising companies in the Canadian health science industry came together at the OBIO Niagara Investment Summit, where they showcased their innovations to over 40 investors from across North America and Japan to pave the path to the investments needed to fully commercialize products.

The OBIO 2020 Niagara Investment Summit national call for applications from health science companies that are seeking Series A or beyond investments is now open.

The Ontario Bioscience Innovation Organization (OBIO®) today released its latest report, ‘Achieving Impact Through Adoption of Innovative Health Technologies: Establishing Early Adopter Health Organizations as an Accelerator for Economic Growth in Ontario’, which describes an early adopter model to facilitate the evaluation and adoption of innovative health technologies in Ontario health organizations.

The Ontario Bioscience Innovation Organization (OBIO®) is proud to announce its 2019 Capital Access Advisory Program (CAAP®) and the high-potential health science companies in this year’s program.

OBIO is proud to announce the opening of the 2019 Niagara Investment Summit in Niagara-on-the-Lake, Ontario, on February 21-22, 2019. The 2019 Niagara Investment Summit will feature over 30 of Canada’s most promising innovative health science companies meeting with more than 30 US and global investors and VCs in Niagara-on-the-Lake to propel investment in Canada’s health science industry.

The Ontario Bioscience Innovation Organization (OBIO®) is honoured to announce the conclusion of the successful Canadian Health Investment Showcase which took place in New York, NY, on November 5 and 6, 2018.

January 24, 2017 TORONTO--(BUSINESS WIRE)--The Ontario Bioscience Innovation Organization (OBIO®) hosted a summit of industry, academic, government and investment leaders about the future of health science innovation in Canada. Attendees engaged in group discussions and heard from subject matter experts to extrapolate a mandate of action for anchoring health science companies in Ontario. The outcome of the summit lays a foundation for actionable business cases for private and public sector solutions to the health science industry’s biggest challenges: Innovation Pull, Adoption and Capital Attraction.